Biocept Inc. (BIOC) went up 5.48% yesterday: Is this the Most Sought-After Stock Today?
Biocept Inc. (NASDAQ: BIOC) started the day on June 22, 2021, with a price increase of 5.48% at $4.43. During the day, the stock rose to $4.97 and sunk to $4.24 before settling in for the price of $4.20 at the close. Taking a more long-term approach, BIOC posted a 52-week range of $3.46-$13.00.
It was noted that the giant of the Healthcare sector posted annual sales growth of 114.10% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 72.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 87.70%. This publicly-traded company’s shares outstanding now amounts to $13.40 million, simultaneously with a float of $13.40 million. The organization now has a market capitalization sitting at $60.29 million. At the time of writing, stock’s 50-day Moving Average stood at $4.52, while the 200-day Moving Average is $5.05.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 104 workers. It has generated 204,936 per worker during the last fiscal year. Meanwhile, its income per employee was -132,887. The stock had 3.11 Receivables turnover and 0.84 Total Asset turnover. For the Profitability, stocks gross margin was +22.30, operating margin was -56.33 and Pretax Margin of -64.84.
Biocept Inc. (BIOC) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Diagnostics & Research Industry. Biocept Inc.’s current insider ownership accounts for 0.02%, in contrast to 10.60% institutional ownership.
Biocept Inc. (BIOC) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/30/2020, the organization reported $0.14 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$0.27) by $0.41. This company achieved a net margin of -64.84 while generating a return on equity of -102.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
Biocept Inc.’s EPS increase for this current 12-month fiscal period is 87.70% and is forecasted to reach -1.26 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 40.00% through the next 5 years, which can be compared against the 72.30% growth it accomplished over the previous five years trading on the market.
Biocept Inc. (NASDAQ: BIOC) Trading Performance Indicators
Let’s observe the current performance indicators for Biocept Inc. (BIOC). It’s Quick Ratio in the last reported quarter now stands at 2.70. The Stock has managed to achieve an average true range (ATR) of 0.23. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.38.
In the same vein, BIOC’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.49, a figure that is expected to reach -0.16 in the next quarter, and analysts are predicting that it will be -1.26 at the market close of one year from today.
Technical Analysis of Biocept Inc. (BIOC)
If we take a close look at the recent performances of Biocept Inc. (NASDAQ: BIOC), its last 5-days Average volume was 1.84 million that shows progress from its year to date volume of 0.49 million. During the previous 9 days, stock’s Stochastic %D was recorded 18.60% While, its Average True Range was 0.25.
Raw Stochastic average of Biocept Inc. (BIOC) in the period of the previous 100 days is set at 9.82%, which indicates a major fall in contrast to 33.33% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 54.78% that was lower than 67.78% volatility it exhibited in the past 100-days period.